284 related articles for article (PubMed ID: 24709226)
1. Palladacycle (BPC) antitumour activity against resistant and metastatic cell lines: the relationship with cytosolic calcium mobilisation and cathepsin B activity.
Bechara A; Barbosa CM; Paredes-Gamero EJ; Garcia DM; Silva LS; Matsuo AL; Nascimento FD; Rodrigues EG; Caires AC; Smaili SS; Bincoletto C
Eur J Med Chem; 2014 May; 79():24-33. PubMed ID: 24709226
[TBL] [Abstract][Full Text] [Related]
2. Biphosphinic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells.
Barbosa CM; Oliveira CR; Nascimento FD; Smith MC; Fausto DM; Soufen MA; Sena E; Araújo RC; Tersariol IL; Bincoletto C; Caires AC
Eur J Pharmacol; 2006 Aug; 542(1-3):37-47. PubMed ID: 16831419
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical antitumour evaluation of Biphosphinic Palladacycle Complex in human leukaemia cells.
Oliveira CR; Barbosa CM; Nascimento FD; Lanetzki CS; Meneghin MB; Pereira FE; Paredes-Gamero EJ; Ferreira AT; Rodrigues T; Queiroz ML; Caires AC; Tersariol IL; Bincoletto C
Chem Biol Interact; 2009 Feb; 177(3):181-9. PubMed ID: 19026616
[TBL] [Abstract][Full Text] [Related]
4. A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells.
Serrano FA; Matsuo AL; Monteforte PT; Bechara A; Smaili SS; Santana DP; Rodrigues T; Pereira FV; Silva LS; Machado J; Santos EL; Pesquero JB; Martins RM; Travassos LR; Caires AC; Rodrigues EG
BMC Cancer; 2011 Jul; 11():296. PubMed ID: 21756336
[TBL] [Abstract][Full Text] [Related]
5. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
6. The biphosphinic paladacycle complex induces melanoma cell death through lysosomal-mitochondrial axis modulation and impaired autophagy.
Gigli R; Pereira GJ; Antunes F; Bechara A; Garcia DM; Spindola DG; Jasiulionis MG; Caires AC; Smaili SS; Bincoletto C
Eur J Med Chem; 2016 Jan; 107():245-54. PubMed ID: 26599531
[TBL] [Abstract][Full Text] [Related]
7. Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis.
Joy B; Sivadasan R; Abraham T E; John M; Sobhan PK; Seervi M; T R S
Mol Carcinog; 2010 Apr; 49(4):324-36. PubMed ID: 19943316
[TBL] [Abstract][Full Text] [Related]
8. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
[TBL] [Abstract][Full Text] [Related]
9. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a 1,4-benzodiazepine containing palladacycle with in vitro anticancer and cathepsin B activity.
Spencer J; Rathnam RP; Motukuri M; Kotha AK; Richardson SC; Hazrati A; Hartley JA; Male L; Hursthouse MB
Dalton Trans; 2009 Jun; (22):4299-303. PubMed ID: 19662306
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation.
González-Sánchez I; Solano JD; Loza-Mejía MA; Olvera-Vázquez S; Rodríguez-Sotres R; Morán J; Lira-Rocha A; Cerbón MA
Eur J Med Chem; 2011 Jun; 46(6):2102-8. PubMed ID: 21420205
[TBL] [Abstract][Full Text] [Related]
12. Mixed valence copper(I,II) binuclear complexes with unexpected structure: synthesis, biological properties and anticancer activity.
Majouga AG; Zvereva MI; Rubtsova MP; Skvortsov DA; Mironov AV; Azhibek DM; Krasnovskaya OO; Gerasimov VM; Udina AV; Vorozhtsov NI; Beloglazkina EK; Agron L; Mikhina LV; Tretyakova AV; Zyk NV; Zefirov NS; Kabanov AV; Dontsova OA
J Med Chem; 2014 Jul; 57(14):6252-8. PubMed ID: 24950478
[TBL] [Abstract][Full Text] [Related]
13. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
14. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anti-glioma activity of a chalcone-quinoxaline hybrid.
Loch-Neckel G; Bicca MA; Leal PC; Mascarello A; Siqueira JM; Calixto JB
Eur J Med Chem; 2015 Jan; 90():93-100. PubMed ID: 25461314
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal and mitochondrial permeabilization mediates zinc(II) cationic phthalocyanine phototoxicity.
Marino J; García Vior MC; Furmento VA; Blank VC; Awruch J; Roguin LP
Int J Biochem Cell Biol; 2013 Nov; 45(11):2553-62. PubMed ID: 23994488
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
18. A novel silver iodide metalo-drug: experimental and computational modelling assessment of its interaction with intracellular DNA, lipoxygenase and glutathione.
Banti CN; Kyros L; Geromichalos GD; Kourkoumelis N; Kubicki M; Hadjikakou SK
Eur J Med Chem; 2014 Apr; 77():388-99. PubMed ID: 24681027
[TBL] [Abstract][Full Text] [Related]
19. Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death.
Nazarov AA; Gardini D; Baquié M; Juillerat-Jeanneret L; Serkova TP; Shevtsova EP; Scopelliti R; Dyson PJ
Dalton Trans; 2013 Feb; 42(7):2347-50. PubMed ID: 23223548
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75.
Mediavilla-Varela M; Pacheco FJ; Almaguel F; Perez J; Sahakian E; Daniels TR; Leoh LS; Padilla A; Wall NR; Lilly MB; De Leon M; Casiano CA
Mol Cancer; 2009 Aug; 8():68. PubMed ID: 19715609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
